an example of this common ground idea is right before our eyes.....
after our tacti-Mel experiment, instigated by immutep with the help
of Australia's PBS scheme which granted relief for melanoma patients
re the cost of keytruda, immuteps collaboration with merck re head and
neck cancer and nsclc have both started at ph 2, saving time and money...
Big Year Ahead, page-118
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.3¢ | $884.2K | 2.836M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34624 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 250082 | 6 |
View Market Depth
| Last trade - 16.10pm 27/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
